All PlansCoverageMedium impact
Withdrawal: Makena
UPMC Health Plan·OB-GYN, Family Medicine·Pharmacy
Effective date
Mar 7, 2023
We identified it
Jun 20, 2026
Summary
Covis Pharma announced the withdrawal of Makena (hydroxyprogesterone caproate injection) from the market on March 7, 2023. This drug was used to reduce preterm birth risk in pregnant women with previous spontaneous preterm birth history.
Action Required
Immediately: Stop dispensing and billing for Makena (hydroxyprogesterone caproate injection). Billing team must update pharmacy systems to remove Makena from formulary. Providers should identify alternative treatments for patients previously prescribed Makena for preterm birth prevention.